Lang, Y., Chai, Q., Lin, Y., Wu, B., & Liu, X. Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: A cost-effectiveness analysis. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLang, Yitian, Qingqing Chai, Yan Lin, Bin Wu, and Xiaoyan Liu. Adding Capivasertib to Fulvestrant in Patients with Hormone Receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis. Frontiers Media S.A.
MLA (9th ed.) CitationLang, Yitian, et al. Adding Capivasertib to Fulvestrant in Patients with Hormone Receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.